CEBP CTRC-AACR San Antonio Breast Cancer Symposium Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yu, C.
Right arrow Articles by Lin, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yu, C.
Right arrow Articles by Lin, D.
Cancer Epidemiology Biomarkers & Prevention Vol. 12, 176, February 2003
© 2003 American Association for Cancer Research


Null Results in Briefs

Lack of Association between CCND1 G870A Polymorphism and Risk of Esophageal Squamous Cell Carcinoma1

Chunyuan Yu, Wenfu Lu, Wen Tan, Deyin Xing, Gang Liang, Xiaoping Miao and Dongxin Lin2

Department of Etiology and Carcinogenesis, Cancer Institute, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China

Introduction

ESCC,3 like most malignant tumors, is primarily a consequent of abnormal cell proliferation induced by uncontrolled cell cycle. Cyclin D1 plays an important role in the transition from G1 to S phase of the cell cycle and has oncogenic properties. Overexpression of this protein is thought to be related to the development of a variety of tumors, including ESCC (1) . The gene encoding cyclin D1, CCND1, has a common G870A polymorphism at codon 242 in exon 4 that increases the frequency of alternate splicing, leading to an altered protein (2) . The altered cyclin D1 does not contain the sequences involved in protein turnover and, thus, may have a longer acting half-life. It has been suggested that this polymorphism in the CCND1 gene confers susceptibility to certain cancers (3, 4, 5) .

In this study, we analyzed DNA samples from a hospital-based case-control study in a Chinese population to test the hypothesis that the CCND1 G870A polymorphism may be a genetic risk modifier for ESCC.

Materials and Methods

This study included 321 patients with ESCC and 345 age- and gender-matched healthy controls. Patients were consecutively recruited from January 1998 to December 2000 at the Cancer Hospital, Chinese Academy of Medical Sciences (Beijing, China). Population controls were accrued from a database of nutritional survey conducted in the same regions. Most of the cases and controls have been characterized in a molecular epidemiological study described elsewhere (6) . The CCND1 G870A genotypes were determined by PCR-restriction fragment length polymorphism method as described previously (4) . The ORs and their 95% CIs calculated by unconditional logistic regression models and adjusted for age, sex, and smoking status were used to estimate risk of ESCC for the CCND1 polymorphism.

Results and Discussion

The allele frequencies for CCND1 870G and 870A were 0.424 and 0.576, respectively, among controls and 0.457 and 0.543, respectively, among cases with ESCC. The distribution of three CCND1 G870A genotypes among cases were not significantly different from that among controls and, thus, the polymorphism did not associated with risk of ESCC (Table 1)Citation . In addition, no evidence for interaction between the polymorphism and tobacco smoking was observed.


View this table:
[in this window]
[in a new window]
 
Table 1 CCND1 G870A genotypes in cases and controls and their association with the risk of esophageal cancer

 
Although this study had sufficient power (80%) to detect risk >1.8, we observed no association between the CCND1 G870A polymorphism and risk of ESCC. These results indicate that the CCND1 G870A genotypes themselves may not be involved in the predisposition to develop ESCC. However, in this study, we did not assay other genetic variations of cell cycle related proteins such as retinoblastoma and p21, which interact with cyclin D1 and also play key roles in cell cycle regulation. Without such information, we cannot exclude the possibility that the CCND1 G870A polymorphism may confer susceptibility to ESCC via functional interaction with other genetic polymorphisms. Therefore, the results of this study highlight the need for additional studies on polygene analysis.

Footnotes

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Supported by National Natural Science Foundation Grant 39825122 and from State Key Basic Research Program Grant G1998051204. Back

2 To whom requests for reprints should be addressed, at Department of Etiology and Carcinogenesis, Cancer Institute, Chinese Academy of Medical Sciences, Beijing 100021, China. Fax: 86-10-67722460; E-mail: dlin{at}public.bta.net.cn Back

3 The abbreviations used are: ESCC, esophageal squamous cell carcinoma; OR, odds ratio; CI, confidence interval. Back

Received 10/11/02; revised 10/11/02; accepted 11/22/02.

References

  1. Jiang W., Zhang Y., Scott M. K., Monica C. H., Regina M. S., Lu S., Curtis C. H., Ruggero M., Bernard W. Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc. Natl. Acad. Sci. USA, 90: 9026-9030, 1993.[Abstract/Free Full Text]
  2. Betticher D. C., Thatcher N., Altermatt H. J., Hoban P., Ryder D. J., Heighway J. Alternate splicing produces a novel cyclin D1 transcript. Oncogene, 11: 1005-1011, 1995.[Medline]
  3. McKay J. A., Douglas J. J., Ross V. G., Curran S., Murray G. I., Cassidy J., McLeod H. J. Cyclin D1 protein expression and gene polymorphism in colorectal cancer. Int. J. Cancer, 88: 77-81, 2000.[Medline]
  4. Zheng Y., Shen H., Erich M. S., Wang L., Susan A. E., Sara S. S., Marsha L. F., Margaret R. S., Wei Q. Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case-control study. Carcinogenesis (Lond.), 22: 1195-1199, 2001.[Abstract/Free Full Text]
  5. Wang L., Habuchi T., Takahashi T., Mitsumori K., Kamoto T., Kakehi Y., Kakinuma H., Sato K., Nakamura A., Ogawa O., Kato T. Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer. Carcinogenesis (Lond.), 23: 257-264, 2002.[Abstract/Free Full Text]
  6. Song C., Xing D., Tan W., Wei Q., Lin D. Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population. Cancer Res., 61: 3272-3275, 2001.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
CarcinogenesisHome page
M. Huang, M. R. Spitz, J. Gu, J.J. Lee, J. Lin, S. M.Lippman, and X. Wu
Cyclin D1 gene polymorphism as a risk factor for oral premalignant lesions
Carcinogenesis, October 1, 2006; 27(10): 2034 - 2037.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Ceschi, C.-L. Sun, D. Van Den Berg, W.-P. Koh, M. C. Yu, and N. Probst-Hensch
The effect of cyclin D1 (CCND1) G870A-polymorphism on breast cancer risk is modified by oxidative stress among Chinese women in Singapore
Carcinogenesis, August 1, 2005; 26(8): 1457 - 1464.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
X. O. Shu, D. B. Moore, Q. Cai, J. Cheng, W. Wen, L. Pierce, H. Cai, Y.-T. Gao, and W. Zheng
Association of Cyclin D1 Genotype with Breast Cancer Risk and Survival
Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 91 - 97.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yu, C.
Right arrow Articles by Lin, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yu, C.
Right arrow Articles by Lin, D.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation